179 related articles for article (PubMed ID: 32646228)
1. Electroacupuncture for post-stroke overactive bladder: a multi-centre pilot randomized controlled trial.
Chen H; Wang C; Zhou M; Yan Chan P; Lo Yam L; Lok Lam W; Leung KP; Li SW; Tsang WY; Fung-Leung Ng B; Tat-Chi Ziea E; Yeung WF; Lao L
Acupunct Med; 2021 Jun; 39(3):175-183. PubMed ID: 32646228
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of acupuncture for elderly overactive bladder population in Hong Kong: study protocol for a randomized controlled trial.
Chan YT; Zhang HW; Guo YQ; Chan TNH; Kwan YK; Lee CK; Ngan K; Lin ZX
Trials; 2018 Jul; 19(1):376. PubMed ID: 30005707
[TBL] [Abstract][Full Text] [Related]
3. Electroacupuncture to treat with Overactive Bladder in Postmenopausal Women: study protocol for a multicenter, randomized, controlled, parallel clinical trial.
Nam EY; Park JY; Jo J; Jung SH; Lim CY; Kim DI
Trials; 2018 Sep; 19(1):493. PubMed ID: 30219086
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cinnamon patch treatment for alleviating symptoms of overactive bladder: A double-blind, randomized, placebo-controlled trial.
Chen LL; Shen YC; Ke CC; Imtiyaz Z; Chen HI; Chang CH; Lee MH
Phytomedicine; 2021 Jan; 80():153380. PubMed ID: 33091856
[TBL] [Abstract][Full Text] [Related]
5. Effects of electroacupuncture on overactive bladder refractory to anticholinergics: a single-blind randomised controlled trial.
Zhang J; Cheng W; Cai M
Acupunct Med; 2015 Oct; 33(5):368-74. PubMed ID: 26040492
[TBL] [Abstract][Full Text] [Related]
6. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of moxibustion for alleviating symptoms of overactive bladder: A prospective, randomized controlled, crossover-design, pilot study.
Lee HY; Yun YJ; Choi JY; Hong JW; Lee I; Park SH; Kwon JN
Medicine (Baltimore); 2018 Aug; 97(34):e12016. PubMed ID: 30142847
[TBL] [Abstract][Full Text] [Related]
8. Effect of electroacupuncture versus solifenacin for moderate and severe overactive bladder: a multi-centre, randomized controlled trial study protocol.
Wen Q; Li N; Wang X; Li H; Tian F; Chen W; Lu Y; Liu Z
BMC Complement Med Ther; 2020 Jul; 20(1):224. PubMed ID: 32678041
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of electroacupuncture at Zhongliao (BL33) and other acupoints for overactive bladder symptoms.
Yang L; Wang Y; Mo Q; Liu Z
Front Med; 2017 Mar; 11(1):129-136. PubMed ID: 28194560
[TBL] [Abstract][Full Text] [Related]
10. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
[TBL] [Abstract][Full Text] [Related]
11. Acupuncture for adults with overactive bladder: A systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Zhou J; Mo Q; Wang Y; Yu J; Liu Z
Medicine (Baltimore); 2018 Feb; 97(8):e9838. PubMed ID: 29465566
[TBL] [Abstract][Full Text] [Related]
12. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
[TBL] [Abstract][Full Text] [Related]
13. Using electroacupuncture with optimized acupoint positioning to predict the efficacy of sacral neuromodulation of refractory overactive bladder: A case report.
Shen J; Luo R; Zhang L; Li Y; Ke L; Gao Z
Medicine (Baltimore); 2019 Nov; 98(45):e17795. PubMed ID: 31702631
[TBL] [Abstract][Full Text] [Related]
14. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
15. [Electroacupuncture for post-stroke urinary incontinence: a multi-center randomized controlled study].
Song FJ; Jiang SH; Zheng SL; Ye TS; Zhang H; Zhu WZ; Chen B; Yang YM; Zhou LS; Liu XX; Wang Q; Fang JH; Liu HF; Ye BH
Zhongguo Zhen Jiu; 2013 Sep; 33(9):769-73. PubMed ID: 24298760
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of acupoint application in patients with overactive bladder: A randomized, placebo-controlled pilot trial.
Tang H; Zhu C; Xu S; Wang Y; Gao J; Zhou P
Explore (NY); 2023; 19(5):749-754. PubMed ID: 37024405
[TBL] [Abstract][Full Text] [Related]
17. Severity of overactive bladder symptoms and response to dose escalation in a randomized, double-blind trial of solifenacin (SUNRISE).
Cardozo L; Amarenco G; Pushkar D; Mikulas J; Drogendijk T; Wright M; Compion G;
BJU Int; 2013 May; 111(5):804-10. PubMed ID: 23294801
[TBL] [Abstract][Full Text] [Related]
18. Overactive Bladder Symptom Scores responsiveness before and after anticholinergic treatment in women with overactive bladder: The pilot study.
Bunyavejchevin S
J Obstet Gynaecol Res; 2017 Jul; 43(7):1189-1193. PubMed ID: 28612999
[TBL] [Abstract][Full Text] [Related]
19. Electroacupuncture for treatment-resistant insomnia: study protocol for a randomised, controlled, assessor-blinded, pilot clinical trial.
Lim JH; Kim KO; Kim SH; Kang CW; Kim BK
BMJ Open; 2020 Feb; 10(2):e034239. PubMed ID: 32107269
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
